Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance

Chuanqi Peng1, Yingyu Huang1, Jie Zheng1

  • 1Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 West Campbell Road, Richardson, TX 75080, USA.

Insights

Renal clearable nanocarriers improve cancer drug delivery by enhancing tumor penetration and reducing side effects. These novel drug delivery systems (DDSs) also aid in body elimination of non-targeted drugs.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Drug Delivery Systems

Background:

  • Clinical translation of cancer nanomedicines faces physiological barriers.
  • Understanding nano-bio interactions is crucial for overcoming these challenges.
  • Development of novel nanocarriers is needed to address limitations in tumor microenvironment penetration and systemic toxicity.

Purpose of the Study:

  • To introduce and explore the potential of renal clearable nanocarriers as an advanced drug delivery system (DDS).
  • To highlight how these nanocarriers can overcome key barriers in cancer nanomedicine translation.
  • To discuss the benefits of renal clearable DDSs for improving therapeutic efficacy and reducing side effects.

Main Methods:

  • The study focuses on the design principles and functional characteristics of renal clearable nanocarriers.
  • It examines their interaction with the biological system, including tumor penetration and macrophage uptake.
  • The elimination pathways and biodistribution of these nanocarriers are considered.

Main Results:

  • Renal clearable nanocarriers facilitate rapid drug penetration into tumor cores.
  • They effectively escape macrophage uptake, preventing clearance from circulation.
  • These nanocarriers enhance the body's elimination of non-targeted anticancer drugs, improving safety.
  • Improved therapeutic efficacies and reduced side effects of anticancer drugs are achieved.

Conclusions:

  • Renal clearable nanocarriers represent a promising advancement in cancer drug delivery.
  • They offer a strategy to enhance tumor-specific drug accumulation and minimize systemic toxicity.
  • Future applications may extend to diagnostic agents, gene editing, and immunotherapy.

Related Concept Videos

Drug Elimination: The Concept of Clearance01:06

Drug Elimination: The Concept of Clearance

Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
3.6K
Drug Clearance: Overview01:06

Drug Clearance: Overview

Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
321
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
247
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.3K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
1.4K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
141